- Veterinary IVF technologies, which include advanced procedures such as oocyte retrieval, in vitro embryo production, and embryo transfer, are becoming increasingly critical in modern animal breeding programs across Europe, especially in livestock and companion animal sectors. These technologies support genetic improvement, increase reproductive efficiency, and help preserve endangered species
- The rising demand for veterinary IVF is primarily driven by the need to enhance animal productivity, manage fertility challenges, and support high-value breeding programs across cattle, swine, equine, and canine populations. In addition, growing awareness of animal reproductive health and increasing investments in veterinary infrastructure contribute to market expansion
- Germany dominated the Europe veterinary in vitro fertilization (IVF) market with the largest revenue share of 32.4% in 2024, supported by a strong presence of advanced veterinary clinics, skilled practitioners, and active research institutions engaged in animal genetics and reproduction
- France is expected to be the fastest growing country in the Europe veterinary in vitro fertilization (IVF) market during the forecast period, driven by government-backed livestock enhancement programs, expanding demand for pedigree breeding, and rising focus on optimizing reproductive outcomes in dairy and meat-producing animals
- The reagents & kits segment dominated the Europe veterinary in vitro fertilization (IVF) market with a market share of 48.6% in 2024, owing to their essential role in all IVF procedures and increasing usage in embryo transfer, ovum pickup, and artificial insemination protocols. These kits are vital for successful outcomes and are widely used in both research and clinical settings
